IFI35 |
EPSTI1 |
AMIGO2 |
IFITM2 |
SLC4A11 |
CMPK2 |
WARS1 |
FAAP100 |
APOL1 |
OASL |
IFI27 |
ISG15 |
OAS3 |
IFI44L |
CD14 |
SLC35F6 |
IFIT3 |
IFI44 |
SAMD9L |
|
IFIT2 |
PARP9 |
SRP9P1 |
|
Pathways |
|
|
Name |
p-value |
FDR |
Interferon signaling |
1.11E-16 |
4.22E-15 |
Interferon alpha/beta signaling |
1.11E-16 |
4.22E-15 |
Cytokine signaling in Immune system |
1.15E-10 |
2.89E-09 |
Immune system |
0.000002540114879 |
0.00004826218271 |
OAS antiviral response |
0.0004764545663 |
0.007146818495 |
Antiviral mechanism by IFN-stimulated genes |
0.001033347261 |
0.01240016713 |
Interferon gamma signaling |
0.001889694619 |
0.02078664081 |
Transfer of LPS from LBP carrier to CD14 |
0.006318772245 |
0.05686895021 |
TRIF-mediated programmed cell death |
0.02091267586 |
0.1656073329 |
MyD88 deficiency (TLR2/4) |
0.03733748271 |
0.1656073329 |
IRAK2-mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.03733748271 |
0.1656073329 |
TRAF6-mediated induction of TAK1 complex within TLR4 complex |
0.03937173812 |
0.1656073329 |
IRAK4 deficiency (TLR2/4) |
0.03937173812 |
0.1656073329 |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.04140183322 |
0.1656073329 |
Caspase activation via death receptors in the presence of ligand |
0.04140183322 |
0.1656073329 |
IKK complex recruitment mediated by RIP1 |
0.04948077476 |
0.1855013265 |